
Medpace Q3 2026 Earnings: The $716M Quarter That Ran on Client Cash
Medpace Q3 2026 revenue rose 8.5% to $716.0M with a 19.2% net margin; diluted EPS jumped 25.4% to $4.84 on operating leverage and a lower tax rate.
#financial-reporting
Create accurate financial reports and statements for better insights

Medpace Q3 2026 revenue rose 8.5% to $716.0M with a 19.2% net margin; diluted EPS jumped 25.4% to $4.84 on operating leverage and a lower tax rate.

Morgan Stanley's Q3 revenue grew 12% to $20.3B on a 41% jump in equities trading and record $9.1B wealth fees; EPS hit $3.03 with ROTCE at 22.6%.

MSC Industrial's Q4 FY2026 sales rose 10.3% to a record $1,079.2M, but a $41.8M digital-core IT impairment cut GAAP EPS to $0.85; adjusted EPS hit $1.45.

Nasdaq Q3 2026: net income rose 28% to $540M as Index revenue jumped 39% on record $49B inflows; software, data and index now earn 79% of net revenue.

Newmont Q3 2026 net income rose 35% to $2.48B on $4,317 gold while output fell 8.5%; $1.9B went back to shareholders ahead of the Red Chris decision.

Norfolk Southern Q3 2026 revenue hit a record $3.53B (+14%), EPS rose 7% to $3.37, and the operating ratio worsened 280 bps to 67.4% as merger costs mounted.

PG&E's Q3 2026 core EPS fell 18% to $0.41 and GAAP EPS 8% to $0.34 on a lower allowed ROE; the $1.64–$1.66 guide held as 2027 capex was cut $2B.

Pool Corp Q3 2026 sales rose 4% to $1.5B, but operating income fell 3% and EPS held flat at $3.40 on buybacks; the guide implies a $0.64–$0.94 Q4.

RLI's Q3 2026 net income fell 35% to $81.0M on a $45.3M equity-mark swing, yet operating EPS rose 4.9% to $0.86 on an 86.2% combined ratio.

Ryder earned $4.16/share in Q3 2026 (+25%) on $3.43B revenue; a ~$4.30 non-cash pension settlement will push Q4 GAAP EPS near zero with equity untouched.

Selective's Q3 2026 EPS rose 14% to $2.11 on a 96.8% combined ratio as net premiums written fell 7% — deliberate shrinkage that is now paying off.

Sallie Mae Q3 2026: record $3.4B of private student loan originations (+15%) produced a $0.19 loss per share; full-year EPS guidance cut to $1.95–$2.05.